CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275414423
- Phone
- (650) 822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- Open-market buys, last 90 days
- $99,829
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$99,829. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-09-13 | Yednock Ted EVP & Chief Scientific Officer | Sale | −16,190 | $20.00 | $324K | 0 |
| 2021-09-13 | Yednock Ted EVP & Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −15,000 | 10,615 | ||
| 2021-09-13 | Yednock Ted EVP & Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −1,190 | 67,939 | ||
| 2021-09-13 | Lew Jennifer EVP & Chief Financial Officer | Option exercise | +3,500 | $7.49 | $26K | 5,500 |
| 2021-09-13 | Lew Jennifer EVP & Chief Financial Officer | Sale | −3,500 | $20.01 | $70K | 2,000 |
| 2021-09-13 | Lew Jennifer EVP & Chief Financial Officer | Option exercise · Stock Option (Right to Buy) | −3,500 | 143,793 | ||
| 2021-08-12 | Waddill William D. Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2021-06-08 | Love Douglas President & CEO | Option exercise | +3,750 | $1.41 | $5K | 3,750 |
| 2021-06-08 | Love Douglas President & CEO | Sale | −3,750 | $22.55 | $85K | 0 |
| 2021-06-08 | Love Douglas President & CEO | Option exercise · Stock Option (Right to Buy) | −3,750 | 45,494 | ||
| 2021-06-07 | Love Douglas President & CEO | Option exercise | +3,750 | $1.41 | $5K | 3,750 |
| 2021-06-07 | Love Douglas President & CEO | Sale | −3,750 | $22.31 | $84K | 0 |
| 2021-06-07 | Love Douglas President & CEO | Option exercise · Stock Option (Right to Buy) | −3,750 | 49,244 | ||
| 2021-06-03 | Yednock Ted EVP & Chief Scientific Officer | Option exercise | +15,000 | $1.41 | $21K | 15,000 |
| 2021-06-03 | Yednock Ted EVP & Chief Scientific Officer | Sale | −12,816 | $21.45 | $275K | 2,184 |
| 2021-06-03 | Yednock Ted EVP & Chief Scientific Officer | Sale | −2,184 | $21.72 | $47K | 0 |
| 2021-06-03 | Yednock Ted EVP & Chief Scientific Officer | Option exercise · Stock Option (Right to Buy) | −15,000 | 25,615 | ||
| 2021-06-02 | Satter Muneer A Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-02 | WIGGANS THOMAS G Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2021-06-02 | Choi Jung Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 |
Page 11 of 15 · 292 trades